Comparison Dyne Therapeutics (DYN) with Competitors
Dyne Therapeutics (DYN) industry is Biotechnology.
Debt-to-Equity
DYN17.27%
Industry28.27%
Upside-38.91%
Free Cash Flow Yield
DYN-11.19%
Industry-1.75%
Upside-9.44%
P/E
DYN-7.65
Industry-20.52
Upside+1287.09%
P/B
DYN4.52
Industry5.15
Upside-12.22%